COALESCENT Trademark

Trademark Overview

On Monday, April 15, 2019, a trademark application was filed for COALESCENT with the United States Patent and Trademark Office. The USPTO has given the COALESCENT trademark a serial number of 88386268. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 14, 2022. This trademark is owned by CytoImmune Therapeutics, LLC. The COALESCENT trademark is filed in the Pharmaceutical Products category with the following description:

Anti-cancer preparations; Pharmaceutical preparations, namely, a drug delivery platform utilizing blood vessel binding to penetrate tumors to deliver anti-cancer preparations
coalescent

General Information

Serial Number88386268
Word MarkCOALESCENT
Filing DateMonday, April 15, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 14, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 13, 2019

Trademark Statements

Goods and ServicesAnti-cancer preparations; Pharmaceutical preparations, namely, a drug delivery platform utilizing blood vessel binding to penetrate tumors to deliver anti-cancer preparations
Pseudo MarkCOALESCE CYTOIMMUNE THERAPEUTICS

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 1, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCYTOIMMUNE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressPASADENA, CA 91107
Party NameCytoImmune Therapeutics, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressPasadena, CA 91107
Party NameCytoImmune Therapeutics, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressPasadena, CA 91107

Trademark Events

Event DateEvent Description
Monday, November 14, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, November 14, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, April 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 6, 2022SOU EXTENSION 5 GRANTED
Tuesday, April 5, 2022SOU EXTENSION 5 FILED
Tuesday, April 5, 2022TEAS EXTENSION RECEIVED
Thursday, October 7, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 5, 2021SOU EXTENSION 4 GRANTED
Tuesday, October 5, 2021SOU EXTENSION 4 FILED
Tuesday, October 5, 2021TEAS EXTENSION RECEIVED
Saturday, April 3, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 1, 2021SOU EXTENSION 3 GRANTED
Thursday, April 1, 2021SOU EXTENSION 3 FILED
Thursday, April 1, 2021TEAS EXTENSION RECEIVED
Tuesday, September 1, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 31, 2020SOU EXTENSION 2 GRANTED
Thursday, August 20, 2020SOU EXTENSION 2 FILED
Monday, August 31, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, August 20, 2020TEAS EXTENSION RECEIVED
Wednesday, August 12, 2020AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, March 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, March 9, 2020SOU EXTENSION 1 GRANTED
Monday, March 9, 2020SOU EXTENSION 1 FILED
Monday, March 9, 2020TEAS EXTENSION RECEIVED
Tuesday, October 8, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 13, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 13, 2019PUBLISHED FOR OPPOSITION
Wednesday, July 24, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, July 8, 2019ASSIGNED TO LIE
Tuesday, June 25, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 25, 2019EXAMINER'S AMENDMENT ENTERED
Tuesday, June 25, 2019NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, June 25, 2019EXAMINERS AMENDMENT E-MAILED
Tuesday, June 25, 2019EXAMINERS AMENDMENT -WRITTEN
Monday, June 24, 2019ASSIGNED TO EXAMINER
Wednesday, May 1, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Thursday, April 18, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

coalescent preparations cancer anti binding vessel tumors deliver blood penetrate platform